ArticleCureus2024
Why People Seek Obesity Care Through Digital Rather Than In-Person Services: A Quantitative Multinational Analysis of Patients From a Large Unsubsidized Digital Obesity Provider.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists.Anaesthesia and intensive care · 2025Guideline
- Effectiveness and adherence in a tirzepatide-supported digital weight-loss programme in Australia: A real-world observational study.Diabetes, obesity & metabolism · 2026Observational
- ChatGPT-4o and 4o1 Preview as Dietary Support Tools in a Real-World Medicated Obesity Program: A Prospective Comparative Analysis.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digital modalities have been demonstrated to improve access and adherence to various chronic care services by mitigating geographical, temporal, and psychological barriers to ongoing multidisciplinary consultations, which such diseases necessitate. The net utility of medication-supported digital weight-loss services (DWLSs) has been intensely debated over the past few years due to their rapid uptake against the backdrop of the obesity epidemic. However, research on these services in real-world settings is scarce. Patients of a large multinational DWLS were emailed a four-question survey, soliciting their reasons for using the service instead of face-to-face (F2F) alternatives. Responses were collected from 1,283 patients, including 481 from the United Kingdom, 428 from Germany, and 374 from Australia. Personal discomfort in discussing weight loss in F2F settings was the most common reason for subscribing to the Eucalyptus DWLS across the full cohort (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.